Speciality: Hematology
Description:
A warm welcome to all the medical professionals in this memorable scientific session on the management of venous thromboembolism in patients of general surgery.
Venous thromboembolism is the most common cause of death observed in surgical patients. The risk of venous thromboembolism (VTE) among the population of postoperative patients is heterogeneous and depends on intrinsic patient factors.
The risk is determined by the combination of different factors and features such as the use of prophylaxis, perioperative care, etc which are related to the type of surgery. It is evident that extended use of prophylaxis, early mobilization, and the implication of improved perioperative care can help in reducing the risk of VTE in surgical patients.
Thus, depending on the risk for VTE and major bleeding in surgical patients combined methods of mechanical and pharmacological prophylaxis or only mechanical prophylaxis may be preferred.
Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Geriatric Assessment, QoL Correlate With OS in Older Patients with Pancreatic Cancer
2.
Higher Binge Drinking Rates Linked to New Cannabis Laws.
3.
Cancer Patients Who Completed Medication Survey Received More Help From Pharmacists
4.
Ketamine plus psychotherapy for "excellent" PTSD
5.
No Seed Oil-Colon Cancer Link; Avoiding Prostate Biopsy; Top Cancer Advances
1.
Revolutionizing Oncology: Pharmacometric Models in Personalized Cancer Drug Development
2.
HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment
3.
Advancing Cancer Trials: Integrating Master Protocols and Immunotherapy Guidelines
4.
Navigating the Stages of Thyroid Cancer: A Guide for Patients
5.
Can We Repurpose BV-CHP for Better Outcomes in Peripheral T-Cell Lymphoma?
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A New Era in Managing Cancer-Associated Thrombosis
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI
3.
Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation